HDAC Inhibition Sensitize Hepatocellular Carcinoma to Lenvatinib via Suppressing AKT Activation
International Journal of Biological Sciences · 2024 · 20 (8) · 3046-3060
DOI: 10.7150/ijbs.93375 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2024. Verfasst von Shuai Yan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Translational Cancer Research Center, Peking University First Hospital, Beijing 100034, China. Hauptthemen laut MEDLINE: Quinolines, Phenylurea Compounds, Carcinoma, Hepatocellular, Histone Deacetylase Inhibitors. Die Arbeit wurde bisher 32-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Translational Cancer Research Center, Peking University First Hospital, Beijing 100034, China.
- Department of Hepatobiliary Tumor, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
- Department of Hepatic Biliary Pancreatic Surgery, Henan Cancer Hospital, Zhengzhou 450000, China.
- Department of General Surgery, Peking University First Hospital, Beijing 100034, China.
- International Cancer Institute, Peking University Health Science Center, Beijing 100191, China.
- Yunnan Baiyao Group, Kunming 650504, China.
Zitieren
APA
Yan, S., Chen, L., Zhuang, H., Yang, H., Yang, Y., Zhang, N., & Liu, R. (2024). HDAC Inhibition Sensitize Hepatocellular Carcinoma to Lenvatinib via Suppressing AKT Activation. International Journal of Biological Sciences, 20(8), 3046-3060. https://doi.org/10.7150/ijbs.93375
Vancouver
Yan S, Chen L, Zhuang H, Yang H, Yang Y, Zhang N, et al. HDAC Inhibition Sensitize Hepatocellular Carcinoma to Lenvatinib via Suppressing AKT Activation. International Journal of Biological Sciences. 2024;20(8):3046-3060. doi:10.7150/ijbs.93375
BibTeX
@article{Yan2024,
author = {Yan, Shuai and Chen, Lu and Zhuang, Hao and Yang, Hui and Yang, Yinmo and Zhang, Ning and Liu, Rong},
title = {HDAC Inhibition Sensitize Hepatocellular Carcinoma to Lenvatinib via Suppressing AKT Activation},
journal = {International Journal of Biological Sciences},
year = {2024},
volume = {20},
number = {8},
pages = {3046--3060},
doi = {10.7150/ijbs.93375}
}
EUVIMED